https://www.selleckchem.com/products/AV-951.html
To describe the adverse events (AEs) of recreational cannabis use in France between 2012 and 2017. AEs related to recreational cannabis use, alone or in combination with alcohol and/or tobacco reported to the French Addictovigilance Network were analysed (excluding cannabidiol and synthetic cannabinoids). Reporting of AEs tripled between 2012 (n =179, 6.3%, 95% confidence interval [CI] = 5.4-7.2) and 2017 (n =562, 10.1%, 95% CI = 9.3-10.9), reaching 2217 cases. They concerned mainly men (76.4%) and users aged between 18 and 34 years (18-
Curtir
Comentario
Compartilhar
